EYENOVIA, INC. Files 8-K Report
Ticker: HYPD · Form: 8-K · Filed: Mar 19, 2024 · CIK: 1682639
| Field | Detail |
|---|---|
| Company | Eyenovia, INC. (HYPD) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, disclosure
TL;DR
EYENOVIA filed an 8-K, likely containing important company updates.
AI Summary
On March 19, 2024, EYENOVIA, INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided text excerpt.
Why It Matters
This 8-K filing indicates that EYENOVIA, INC. is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain specific financial or operational details that would indicate high risk.
Key Players & Entities
- EYENOVIA, INC. (company) — Registrant
- March 19, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 295 Madison Avenue, Suite 2400, New York, NY 10017 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for EYENOVIA, INC.?
The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was this 8-K report filed?
The report was filed on March 19, 2024.
In which state is EYENOVIA, INC. incorporated?
EYENOVIA, INC. is incorporated in Delaware.
What is the principal executive office address for EYENOVIA, INC.?
The principal executive office is located at 295 Madison Avenue, Suite 2400, New York, NY 10017.
What is the SEC file number for EYENOVIA, INC.?
The SEC file number is 001-38365.
Filing Stats: 510 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-03-19 08:39:34
Key Financial Figures
- $0.0001 — h registered) Common stock, par value $0.0001 per share EYEN The Nasdaq Stock Mar
Filing Documents
- tm249014d1_8k.htm (8-K) — 24KB
- tm249014d1_ex99-1.htm (EX-99.1) — 55KB
- tm249014d1_ex99-1img01.jpg (GRAPHIC) — 121KB
- tm249014d1_ex99-1img02.jpg (GRAPHIC) — 294KB
- tm249014d1_ex99-1img03.jpg (GRAPHIC) — 180KB
- tm249014d1_ex99-1img04.jpg (GRAPHIC) — 167KB
- tm249014d1_ex99-1img05.jpg (GRAPHIC) — 136KB
- tm249014d1_ex99-1img06.jpg (GRAPHIC) — 154KB
- tm249014d1_ex99-1img07.jpg (GRAPHIC) — 166KB
- tm249014d1_ex99-1img08.jpg (GRAPHIC) — 165KB
- tm249014d1_ex99-1img09.jpg (GRAPHIC) — 178KB
- tm249014d1_ex99-1img10.jpg (GRAPHIC) — 127KB
- tm249014d1_ex99-1img11.jpg (GRAPHIC) — 118KB
- tm249014d1_ex99-1img12.jpg (GRAPHIC) — 201KB
- tm249014d1_ex99-1img13.jpg (GRAPHIC) — 162KB
- tm249014d1_ex99-1img14.jpg (GRAPHIC) — 196KB
- tm249014d1_ex99-1img15.jpg (GRAPHIC) — 166KB
- tm249014d1_ex99-1img16.jpg (GRAPHIC) — 150KB
- tm249014d1_ex99-1img17.jpg (GRAPHIC) — 153KB
- tm249014d1_ex99-1img18.jpg (GRAPHIC) — 149KB
- tm249014d1_ex99-1img19.jpg (GRAPHIC) — 166KB
- tm249014d1_ex99-1img20.jpg (GRAPHIC) — 172KB
- tm249014d1_ex99-1img21.jpg (GRAPHIC) — 168KB
- tm249014d1_ex99-1img22.jpg (GRAPHIC) — 106KB
- tm249014d1_ex99-1img23.jpg (GRAPHIC) — 127KB
- tm249014d1_ex99-1img24.jpg (GRAPHIC) — 99KB
- tm249014d1_ex99-1img25.jpg (GRAPHIC) — 146KB
- tm249014d1_ex99-1img26.jpg (GRAPHIC) — 208KB
- tm249014d1_ex99-1img27.jpg (GRAPHIC) — 254KB
- tm249014d1_ex99-1img28.jpg (GRAPHIC) — 123KB
- tm249014d1_ex99-1img29.jpg (GRAPHIC) — 183KB
- tm249014d1_ex99-1img30.jpg (GRAPHIC) — 103KB
- tm249014d1_ex99-1img31.jpg (GRAPHIC) — 179KB
- tm249014d1_ex99-1img32.jpg (GRAPHIC) — 102KB
- tm249014d1_ex99-1img33.jpg (GRAPHIC) — 138KB
- tm249014d1_ex99-1img34.jpg (GRAPHIC) — 276KB
- tm249014d1_ex99-1img35.jpg (GRAPHIC) — 144KB
- 0001104659-24-035921.txt ( ) — 8087KB
- eyen-20240319.xsd (EX-101.SCH) — 3KB
- eyen-20240319_lab.xml (EX-101.LAB) — 33KB
- eyen-20240319_pre.xml (EX-101.PRE) — 22KB
- tm249014d1_8k_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On March 19, 2024, Eyenovia, Inc. (the "Company") began using an updated corporate presentation with various investors and analysts. A copy of the presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in this Item 7.01, including Exhibit 99.1, is being "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that Section or Sections 11 and 12(a)(2) of the Securities Act. The information contained in this Item 7.01, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act or into any filing or other document pursuant to the Exchange Act, except as otherwise expressly stated in any such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d)Exhibits Exhibit No. Description 99.1 Eyenovia, Inc. Updated Corporate Presentation, dated March 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EYENOVIA, INC. Date: March 19, 2024 /s/ John Gandolfo John Gandolfo Chief Financial Officer